nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR5—hindbrain—obesity	0.0183	0.117	CbGeAlD
Octreotide—SSTR3—hindbrain—obesity	0.0176	0.112	CbGeAlD
Octreotide—SSTR1—hindbrain—obesity	0.0139	0.0886	CbGeAlD
Octreotide—SSTR4—respiratory system—obesity	0.0132	0.084	CbGeAlD
Octreotide—SSTR2—hindbrain—obesity	0.0118	0.0754	CbGeAlD
Octreotide—SSTR4—digestive system—obesity	0.00837	0.0534	CbGeAlD
Octreotide—SSTR5—pituitary gland—obesity	0.00759	0.0484	CbGeAlD
Octreotide—SSTR3—pituitary gland—obesity	0.00727	0.0464	CbGeAlD
Octreotide—SSTR4—endocrine gland—obesity	0.00691	0.0441	CbGeAlD
Octreotide—SSTR5—endocrine gland—obesity	0.00588	0.0375	CbGeAlD
Octreotide—SSTR1—pituitary gland—obesity	0.00575	0.0367	CbGeAlD
Octreotide—SSTR3—endocrine gland—obesity	0.00564	0.036	CbGeAlD
Octreotide—SSTR2—pituitary gland—obesity	0.00489	0.0312	CbGeAlD
Octreotide—SSTR2—digestive system—obesity	0.00458	0.0293	CbGeAlD
Octreotide—SSTR1—endocrine gland—obesity	0.00445	0.0284	CbGeAlD
Octreotide—SSTR1—liver—obesity	0.00402	0.0256	CbGeAlD
Octreotide—SSTR2—endocrine gland—obesity	0.00379	0.0242	CbGeAlD
Octreotide—MPO—respiratory system—obesity	0.00273	0.0174	CbGeAlD
Octreotide—MPO—cardiovascular system—obesity	0.00209	0.0133	CbGeAlD
Octreotide—MPO—pituitary gland—obesity	0.00185	0.0118	CbGeAlD
Octreotide—MPO—digestive system—obesity	0.00174	0.0111	CbGeAlD
Octreotide—MPO—adrenal gland—obesity	0.00165	0.0106	CbGeAlD
Octreotide—MPO—endocrine gland—obesity	0.00143	0.00916	CbGeAlD
Octreotide—MPO—liver—obesity	0.00129	0.00825	CbGeAlD
Octreotide—Psychotic disorder—Topiramate—obesity	0.000296	0.000725	CcSEcCtD
Octreotide—Vertigo—Sibutramine—obesity	0.000295	0.000723	CcSEcCtD
Octreotide—Syncope—Sibutramine—obesity	0.000295	0.000722	CcSEcCtD
Octreotide—Convulsion—Orlistat—obesity	0.000294	0.00072	CcSEcCtD
Octreotide—Arrhythmia—Bupropion—obesity	0.000294	0.00072	CcSEcCtD
Octreotide—Alopecia—Bupropion—obesity	0.000291	0.000712	CcSEcCtD
Octreotide—Palpitations—Sibutramine—obesity	0.00029	0.000711	CcSEcCtD
Octreotide—Irritability—Topiramate—obesity	0.000289	0.000708	CcSEcCtD
Octreotide—Chest pain—Orlistat—obesity	0.000289	0.000708	CcSEcCtD
Octreotide—Myalgia—Orlistat—obesity	0.000289	0.000708	CcSEcCtD
Octreotide—Loss of consciousness—Sibutramine—obesity	0.000289	0.000707	CcSEcCtD
Octreotide—Mental disorder—Bupropion—obesity	0.000288	0.000706	CcSEcCtD
Octreotide—Anxiety—Orlistat—obesity	0.000288	0.000705	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000287	0.000703	CcSEcCtD
Octreotide—Cough—Sibutramine—obesity	0.000287	0.000702	CcSEcCtD
Octreotide—Malnutrition—Bupropion—obesity	0.000286	0.000701	CcSEcCtD
Octreotide—Discomfort—Orlistat—obesity	0.000286	0.000699	CcSEcCtD
Octreotide—Convulsion—Sibutramine—obesity	0.000285	0.000697	CcSEcCtD
Octreotide—Hypertension—Sibutramine—obesity	0.000284	0.000695	CcSEcCtD
Octreotide—Dry mouth—Orlistat—obesity	0.000283	0.000692	CcSEcCtD
Octreotide—Flatulence—Bupropion—obesity	0.000282	0.000691	CcSEcCtD
Octreotide—Dehydration—Topiramate—obesity	0.000282	0.00069	CcSEcCtD
Octreotide—Tension—Bupropion—obesity	0.000281	0.000688	CcSEcCtD
Octreotide—Myalgia—Sibutramine—obesity	0.00028	0.000685	CcSEcCtD
Octreotide—Chest pain—Sibutramine—obesity	0.00028	0.000685	CcSEcCtD
Octreotide—Arthralgia—Sibutramine—obesity	0.00028	0.000685	CcSEcCtD
Octreotide—Anxiety—Sibutramine—obesity	0.000279	0.000683	CcSEcCtD
Octreotide—Nervousness—Bupropion—obesity	0.000278	0.000681	CcSEcCtD
Octreotide—Anaphylactic shock—Orlistat—obesity	0.000277	0.000679	CcSEcCtD
Octreotide—Oedema—Orlistat—obesity	0.000277	0.000679	CcSEcCtD
Octreotide—Back pain—Bupropion—obesity	0.000277	0.000678	CcSEcCtD
Octreotide—Abdominal pain upper—Topiramate—obesity	0.000277	0.000678	CcSEcCtD
Octreotide—Discomfort—Sibutramine—obesity	0.000276	0.000677	CcSEcCtD
Octreotide—Muscle spasms—Bupropion—obesity	0.000275	0.000674	CcSEcCtD
Octreotide—Infection—Orlistat—obesity	0.000275	0.000674	CcSEcCtD
Octreotide—Dry mouth—Sibutramine—obesity	0.000274	0.00067	CcSEcCtD
Octreotide—Nervous system disorder—Orlistat—obesity	0.000272	0.000665	CcSEcCtD
Octreotide—Nasopharyngitis—Topiramate—obesity	0.000271	0.000664	CcSEcCtD
Octreotide—Vision blurred—Bupropion—obesity	0.00027	0.000661	CcSEcCtD
Octreotide—Skin disorder—Orlistat—obesity	0.000269	0.000659	CcSEcCtD
Octreotide—Tremor—Bupropion—obesity	0.000268	0.000657	CcSEcCtD
Octreotide—Gastritis—Topiramate—obesity	0.000268	0.000657	CcSEcCtD
Octreotide—Anaphylactic shock—Sibutramine—obesity	0.000268	0.000657	CcSEcCtD
Octreotide—Oedema—Sibutramine—obesity	0.000268	0.000657	CcSEcCtD
Octreotide—Hyperhidrosis—Orlistat—obesity	0.000268	0.000656	CcSEcCtD
Octreotide—Muscular weakness—Topiramate—obesity	0.000267	0.000654	CcSEcCtD
Octreotide—Infection—Sibutramine—obesity	0.000266	0.000652	CcSEcCtD
Octreotide—Ill-defined disorder—Bupropion—obesity	0.000266	0.000651	CcSEcCtD
Octreotide—Anaemia—Bupropion—obesity	0.000265	0.000648	CcSEcCtD
Octreotide—Shock—Sibutramine—obesity	0.000264	0.000646	CcSEcCtD
Octreotide—Abdominal distension—Topiramate—obesity	0.000264	0.000646	CcSEcCtD
Octreotide—Agitation—Bupropion—obesity	0.000263	0.000645	CcSEcCtD
Octreotide—Thrombocytopenia—Sibutramine—obesity	0.000263	0.000643	CcSEcCtD
Octreotide—Asthma—Topiramate—obesity	0.000262	0.000641	CcSEcCtD
Octreotide—Tachycardia—Sibutramine—obesity	0.000262	0.000641	CcSEcCtD
Octreotide—Skin disorder—Sibutramine—obesity	0.00026	0.000638	CcSEcCtD
Octreotide—Hyperhidrosis—Sibutramine—obesity	0.000259	0.000635	CcSEcCtD
Octreotide—Malaise—Bupropion—obesity	0.000258	0.000633	CcSEcCtD
Octreotide—Vertigo—Bupropion—obesity	0.000257	0.00063	CcSEcCtD
Octreotide—Syncope—Bupropion—obesity	0.000257	0.000629	CcSEcCtD
Octreotide—Pancreatitis—Topiramate—obesity	0.000257	0.000629	CcSEcCtD
Octreotide—Anorexia—Sibutramine—obesity	0.000256	0.000626	CcSEcCtD
Octreotide—Sweating increased—Topiramate—obesity	0.000255	0.000625	CcSEcCtD
Octreotide—Palpitations—Bupropion—obesity	0.000253	0.00062	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Orlistat—obesity	0.000252	0.000618	CcSEcCtD
Octreotide—Bronchitis—Topiramate—obesity	0.000252	0.000617	CcSEcCtD
Octreotide—Loss of consciousness—Bupropion—obesity	0.000252	0.000616	CcSEcCtD
Octreotide—Abdominal discomfort—Topiramate—obesity	0.000251	0.000615	CcSEcCtD
Octreotide—Insomnia—Orlistat—obesity	0.000251	0.000614	CcSEcCtD
Octreotide—Cough—Bupropion—obesity	0.00025	0.000612	CcSEcCtD
Octreotide—Paraesthesia—Orlistat—obesity	0.000249	0.000609	CcSEcCtD
Octreotide—Convulsion—Bupropion—obesity	0.000248	0.000608	CcSEcCtD
Octreotide—Hypertension—Bupropion—obesity	0.000247	0.000606	CcSEcCtD
Octreotide—Dysuria—Topiramate—obesity	0.000245	0.0006	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Sibutramine—obesity	0.000244	0.000598	CcSEcCtD
Octreotide—Dyspepsia—Orlistat—obesity	0.000244	0.000597	CcSEcCtD
Octreotide—Arthralgia—Bupropion—obesity	0.000244	0.000597	CcSEcCtD
Octreotide—Chest pain—Bupropion—obesity	0.000244	0.000597	CcSEcCtD
Octreotide—Myalgia—Bupropion—obesity	0.000244	0.000597	CcSEcCtD
Octreotide—Upper respiratory tract infection—Topiramate—obesity	0.000243	0.000596	CcSEcCtD
Octreotide—Anxiety—Bupropion—obesity	0.000243	0.000595	CcSEcCtD
Octreotide—Insomnia—Sibutramine—obesity	0.000243	0.000594	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000242	0.000593	CcSEcCtD
Octreotide—Pollakiuria—Topiramate—obesity	0.000242	0.000592	CcSEcCtD
Octreotide—Discomfort—Bupropion—obesity	0.000241	0.00059	CcSEcCtD
Octreotide—Decreased appetite—Orlistat—obesity	0.000241	0.00059	CcSEcCtD
Octreotide—Paraesthesia—Sibutramine—obesity	0.000241	0.00059	CcSEcCtD
Octreotide—Gastrointestinal disorder—Orlistat—obesity	0.000239	0.000586	CcSEcCtD
Octreotide—Dyspnoea—Sibutramine—obesity	0.000239	0.000585	CcSEcCtD
Octreotide—Fatigue—Orlistat—obesity	0.000239	0.000585	CcSEcCtD
Octreotide—Dry mouth—Bupropion—obesity	0.000238	0.000584	CcSEcCtD
Octreotide—Somnolence—Sibutramine—obesity	0.000238	0.000584	CcSEcCtD
Octreotide—Weight increased—Topiramate—obesity	0.000238	0.000584	CcSEcCtD
Octreotide—Weight decreased—Topiramate—obesity	0.000237	0.00058	CcSEcCtD
Octreotide—Pain—Orlistat—obesity	0.000237	0.00058	CcSEcCtD
Octreotide—Hyperglycaemia—Topiramate—obesity	0.000236	0.000579	CcSEcCtD
Octreotide—Dyspepsia—Sibutramine—obesity	0.000236	0.000578	CcSEcCtD
Octreotide—Pneumonia—Topiramate—obesity	0.000235	0.000575	CcSEcCtD
Octreotide—Oedema—Bupropion—obesity	0.000234	0.000572	CcSEcCtD
Octreotide—Anaphylactic shock—Bupropion—obesity	0.000234	0.000572	CcSEcCtD
Octreotide—Decreased appetite—Sibutramine—obesity	0.000233	0.000571	CcSEcCtD
Octreotide—Depression—Topiramate—obesity	0.000233	0.00057	CcSEcCtD
Octreotide—Infection—Bupropion—obesity	0.000232	0.000569	CcSEcCtD
Octreotide—Gastrointestinal disorder—Sibutramine—obesity	0.000231	0.000567	CcSEcCtD
Octreotide—Shock—Bupropion—obesity	0.00023	0.000563	CcSEcCtD
Octreotide—Constipation—Sibutramine—obesity	0.000229	0.000562	CcSEcCtD
Octreotide—Pain—Sibutramine—obesity	0.000229	0.000562	CcSEcCtD
Octreotide—Nervous system disorder—Bupropion—obesity	0.000229	0.000561	CcSEcCtD
Octreotide—Neuropathy peripheral—Topiramate—obesity	0.000229	0.000561	CcSEcCtD
Octreotide—Thrombocytopenia—Bupropion—obesity	0.000229	0.00056	CcSEcCtD
Octreotide—Feeling abnormal—Orlistat—obesity	0.000228	0.000559	CcSEcCtD
Octreotide—Tachycardia—Bupropion—obesity	0.000228	0.000559	CcSEcCtD
Octreotide—Skin disorder—Bupropion—obesity	0.000227	0.000556	CcSEcCtD
Octreotide—Urinary tract infection—Topiramate—obesity	0.000227	0.000556	CcSEcCtD
Octreotide—Conjunctivitis—Topiramate—obesity	0.000227	0.000556	CcSEcCtD
Octreotide—Gastrointestinal pain—Orlistat—obesity	0.000227	0.000555	CcSEcCtD
Octreotide—Hyperhidrosis—Bupropion—obesity	0.000226	0.000553	CcSEcCtD
Octreotide—Anorexia—Bupropion—obesity	0.000223	0.000546	CcSEcCtD
Octreotide—Haematuria—Topiramate—obesity	0.000223	0.000545	CcSEcCtD
Octreotide—Feeling abnormal—Sibutramine—obesity	0.000221	0.000541	CcSEcCtD
Octreotide—Epistaxis—Topiramate—obesity	0.00022	0.000539	CcSEcCtD
Octreotide—Urticaria—Orlistat—obesity	0.00022	0.000539	CcSEcCtD
Octreotide—Gastrointestinal pain—Sibutramine—obesity	0.000219	0.000537	CcSEcCtD
Octreotide—Sinusitis—Topiramate—obesity	0.000219	0.000536	CcSEcCtD
Octreotide—Abdominal pain—Orlistat—obesity	0.000219	0.000536	CcSEcCtD
Octreotide—Body temperature increased—Orlistat—obesity	0.000219	0.000536	CcSEcCtD
Octreotide—Bradycardia—Topiramate—obesity	0.000213	0.000523	CcSEcCtD
Octreotide—Urticaria—Sibutramine—obesity	0.000213	0.000522	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Bupropion—obesity	0.000213	0.000522	CcSEcCtD
Octreotide—Body temperature increased—Sibutramine—obesity	0.000212	0.000519	CcSEcCtD
Octreotide—Abdominal pain—Sibutramine—obesity	0.000212	0.000519	CcSEcCtD
Octreotide—Insomnia—Bupropion—obesity	0.000211	0.000518	CcSEcCtD
Octreotide—Rhinitis—Topiramate—obesity	0.00021	0.000515	CcSEcCtD
Octreotide—Paraesthesia—Bupropion—obesity	0.00021	0.000514	CcSEcCtD
Octreotide—Hepatitis—Topiramate—obesity	0.00021	0.000513	CcSEcCtD
Octreotide—Hypoaesthesia—Topiramate—obesity	0.000209	0.000511	CcSEcCtD
Octreotide—Dyspnoea—Bupropion—obesity	0.000208	0.00051	CcSEcCtD
Octreotide—Pharyngitis—Topiramate—obesity	0.000208	0.000509	CcSEcCtD
Octreotide—Somnolence—Bupropion—obesity	0.000208	0.000509	CcSEcCtD
Octreotide—Oedema peripheral—Topiramate—obesity	0.000206	0.000506	CcSEcCtD
Octreotide—Dyspepsia—Bupropion—obesity	0.000206	0.000504	CcSEcCtD
Octreotide—Hypersensitivity—Orlistat—obesity	0.000204	0.0005	CcSEcCtD
Octreotide—Decreased appetite—Bupropion—obesity	0.000203	0.000498	CcSEcCtD
Octreotide—Visual impairment—Topiramate—obesity	0.000202	0.000495	CcSEcCtD
Octreotide—Gastrointestinal disorder—Bupropion—obesity	0.000202	0.000494	CcSEcCtD
Octreotide—Fatigue—Bupropion—obesity	0.000202	0.000494	CcSEcCtD
Octreotide—Pain—Bupropion—obesity	0.0002	0.00049	CcSEcCtD
Octreotide—Constipation—Bupropion—obesity	0.0002	0.00049	CcSEcCtD
Octreotide—Asthenia—Orlistat—obesity	0.000199	0.000487	CcSEcCtD
Octreotide—Hypersensitivity—Sibutramine—obesity	0.000198	0.000484	CcSEcCtD
Octreotide—Pruritus—Orlistat—obesity	0.000196	0.00048	CcSEcCtD
Octreotide—Tinnitus—Topiramate—obesity	0.000195	0.000479	CcSEcCtD
Octreotide—Flushing—Topiramate—obesity	0.000195	0.000476	CcSEcCtD
Octreotide—Cardiac disorder—Topiramate—obesity	0.000195	0.000476	CcSEcCtD
Octreotide—Feeling abnormal—Bupropion—obesity	0.000193	0.000472	CcSEcCtD
Octreotide—Asthenia—Sibutramine—obesity	0.000192	0.000471	CcSEcCtD
Octreotide—Gastrointestinal pain—Bupropion—obesity	0.000191	0.000468	CcSEcCtD
Octreotide—Pruritus—Sibutramine—obesity	0.00019	0.000465	CcSEcCtD
Octreotide—Diarrhoea—Orlistat—obesity	0.00019	0.000464	CcSEcCtD
Octreotide—Immune system disorder—Topiramate—obesity	0.000189	0.000464	CcSEcCtD
Octreotide—Urticaria—Bupropion—obesity	0.000186	0.000455	CcSEcCtD
Octreotide—Alopecia—Topiramate—obesity	0.000185	0.000454	CcSEcCtD
Octreotide—Abdominal pain—Bupropion—obesity	0.000185	0.000453	CcSEcCtD
Octreotide—Body temperature increased—Bupropion—obesity	0.000185	0.000453	CcSEcCtD
Octreotide—Mental disorder—Topiramate—obesity	0.000184	0.00045	CcSEcCtD
Octreotide—Diarrhoea—Sibutramine—obesity	0.000183	0.000449	CcSEcCtD
Octreotide—Dizziness—Orlistat—obesity	0.000183	0.000449	CcSEcCtD
Octreotide—Malnutrition—Topiramate—obesity	0.000182	0.000447	CcSEcCtD
Octreotide—Erythema—Topiramate—obesity	0.000182	0.000447	CcSEcCtD
Octreotide—Flatulence—Topiramate—obesity	0.00018	0.00044	CcSEcCtD
Octreotide—Tension—Topiramate—obesity	0.000179	0.000439	CcSEcCtD
Octreotide—Dizziness—Sibutramine—obesity	0.000177	0.000434	CcSEcCtD
Octreotide—Nervousness—Topiramate—obesity	0.000177	0.000434	CcSEcCtD
Octreotide—Back pain—Topiramate—obesity	0.000177	0.000432	CcSEcCtD
Octreotide—Vomiting—Orlistat—obesity	0.000176	0.000431	CcSEcCtD
Octreotide—Muscle spasms—Topiramate—obesity	0.000175	0.00043	CcSEcCtD
Octreotide—Rash—Orlistat—obesity	0.000175	0.000428	CcSEcCtD
Octreotide—Dermatitis—Orlistat—obesity	0.000175	0.000427	CcSEcCtD
Octreotide—Headache—Orlistat—obesity	0.000174	0.000425	CcSEcCtD
Octreotide—Hypersensitivity—Bupropion—obesity	0.000172	0.000422	CcSEcCtD
Octreotide—Vision blurred—Topiramate—obesity	0.000172	0.000421	CcSEcCtD
Octreotide—Tremor—Topiramate—obesity	0.000171	0.000419	CcSEcCtD
Octreotide—Vomiting—Sibutramine—obesity	0.00017	0.000418	CcSEcCtD
Octreotide—Ill-defined disorder—Topiramate—obesity	0.000169	0.000415	CcSEcCtD
Octreotide—Rash—Sibutramine—obesity	0.000169	0.000414	CcSEcCtD
Octreotide—Dermatitis—Sibutramine—obesity	0.000169	0.000414	CcSEcCtD
Octreotide—Anaemia—Topiramate—obesity	0.000169	0.000413	CcSEcCtD
Octreotide—Headache—Sibutramine—obesity	0.000168	0.000411	CcSEcCtD
Octreotide—Asthenia—Bupropion—obesity	0.000168	0.000411	CcSEcCtD
Octreotide—Agitation—Topiramate—obesity	0.000168	0.000411	CcSEcCtD
Octreotide—Pruritus—Bupropion—obesity	0.000165	0.000405	CcSEcCtD
Octreotide—Nausea—Orlistat—obesity	0.000165	0.000403	CcSEcCtD
Octreotide—Malaise—Topiramate—obesity	0.000165	0.000403	CcSEcCtD
Octreotide—Vertigo—Topiramate—obesity	0.000164	0.000401	CcSEcCtD
Octreotide—Syncope—Topiramate—obesity	0.000164	0.000401	CcSEcCtD
Octreotide—Palpitations—Topiramate—obesity	0.000161	0.000395	CcSEcCtD
Octreotide—Loss of consciousness—Topiramate—obesity	0.00016	0.000393	CcSEcCtD
Octreotide—Diarrhoea—Bupropion—obesity	0.00016	0.000392	CcSEcCtD
Octreotide—Nausea—Sibutramine—obesity	0.000159	0.00039	CcSEcCtD
Octreotide—Cough—Topiramate—obesity	0.000159	0.00039	CcSEcCtD
Octreotide—Convulsion—Topiramate—obesity	0.000158	0.000387	CcSEcCtD
Octreotide—Hypertension—Topiramate—obesity	0.000158	0.000386	CcSEcCtD
Octreotide—Arthralgia—Topiramate—obesity	0.000155	0.00038	CcSEcCtD
Octreotide—Chest pain—Topiramate—obesity	0.000155	0.00038	CcSEcCtD
Octreotide—Myalgia—Topiramate—obesity	0.000155	0.00038	CcSEcCtD
Octreotide—Anxiety—Topiramate—obesity	0.000155	0.000379	CcSEcCtD
Octreotide—Dizziness—Bupropion—obesity	0.000155	0.000379	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000154	0.000378	CcSEcCtD
Octreotide—Discomfort—Topiramate—obesity	0.000153	0.000376	CcSEcCtD
Octreotide—Dry mouth—Topiramate—obesity	0.000152	0.000372	CcSEcCtD
Octreotide—Oedema—Topiramate—obesity	0.000149	0.000365	CcSEcCtD
Octreotide—Vomiting—Bupropion—obesity	0.000149	0.000364	CcSEcCtD
Octreotide—Infection—Topiramate—obesity	0.000148	0.000362	CcSEcCtD
Octreotide—Rash—Bupropion—obesity	0.000147	0.000361	CcSEcCtD
Octreotide—Dermatitis—Bupropion—obesity	0.000147	0.000361	CcSEcCtD
Octreotide—Shock—Topiramate—obesity	0.000147	0.000359	CcSEcCtD
Octreotide—Headache—Bupropion—obesity	0.000146	0.000359	CcSEcCtD
Octreotide—Nervous system disorder—Topiramate—obesity	0.000146	0.000358	CcSEcCtD
Octreotide—Thrombocytopenia—Topiramate—obesity	0.000146	0.000357	CcSEcCtD
Octreotide—Tachycardia—Topiramate—obesity	0.000145	0.000356	CcSEcCtD
Octreotide—Skin disorder—Topiramate—obesity	0.000145	0.000354	CcSEcCtD
Octreotide—Hyperhidrosis—Topiramate—obesity	0.000144	0.000353	CcSEcCtD
Octreotide—Anorexia—Topiramate—obesity	0.000142	0.000348	CcSEcCtD
Octreotide—Nausea—Bupropion—obesity	0.000139	0.00034	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Topiramate—obesity	0.000136	0.000332	CcSEcCtD
Octreotide—Insomnia—Topiramate—obesity	0.000135	0.00033	CcSEcCtD
Octreotide—Paraesthesia—Topiramate—obesity	0.000134	0.000327	CcSEcCtD
Octreotide—Dyspnoea—Topiramate—obesity	0.000133	0.000325	CcSEcCtD
Octreotide—Somnolence—Topiramate—obesity	0.000132	0.000324	CcSEcCtD
Octreotide—Dyspepsia—Topiramate—obesity	0.000131	0.000321	CcSEcCtD
Octreotide—Decreased appetite—Topiramate—obesity	0.000129	0.000317	CcSEcCtD
Octreotide—Gastrointestinal disorder—Topiramate—obesity	0.000129	0.000315	CcSEcCtD
Octreotide—Fatigue—Topiramate—obesity	0.000128	0.000314	CcSEcCtD
Octreotide—Pain—Topiramate—obesity	0.000127	0.000312	CcSEcCtD
Octreotide—Constipation—Topiramate—obesity	0.000127	0.000312	CcSEcCtD
Octreotide—Feeling abnormal—Topiramate—obesity	0.000123	0.000301	CcSEcCtD
Octreotide—Gastrointestinal pain—Topiramate—obesity	0.000122	0.000298	CcSEcCtD
Octreotide—Urticaria—Topiramate—obesity	0.000118	0.00029	CcSEcCtD
Octreotide—Body temperature increased—Topiramate—obesity	0.000118	0.000288	CcSEcCtD
Octreotide—Abdominal pain—Topiramate—obesity	0.000118	0.000288	CcSEcCtD
Octreotide—Hypersensitivity—Topiramate—obesity	0.00011	0.000269	CcSEcCtD
Octreotide—Asthenia—Topiramate—obesity	0.000107	0.000262	CcSEcCtD
Octreotide—Pruritus—Topiramate—obesity	0.000105	0.000258	CcSEcCtD
Octreotide—Diarrhoea—Topiramate—obesity	0.000102	0.00025	CcSEcCtD
Octreotide—Dizziness—Topiramate—obesity	9.85e-05	0.000241	CcSEcCtD
Octreotide—Vomiting—Topiramate—obesity	9.47e-05	0.000232	CcSEcCtD
Octreotide—Rash—Topiramate—obesity	9.39e-05	0.00023	CcSEcCtD
Octreotide—Dermatitis—Topiramate—obesity	9.38e-05	0.00023	CcSEcCtD
Octreotide—Headache—Topiramate—obesity	9.33e-05	0.000228	CcSEcCtD
Octreotide—Nausea—Topiramate—obesity	8.85e-05	0.000217	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTPN1—obesity	3.14e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GCG—obesity	3.14e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LPL—obesity	3.14e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—obesity	3.13e-05	7.2e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT2—obesity	3.13e-05	7.18e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3R1—obesity	3.12e-05	7.18e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FOXO1—obesity	3.11e-05	7.16e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RPS6KB1—obesity	3.11e-05	7.15e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IRS1—obesity	3.1e-05	7.11e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FOXO3—obesity	3.08e-05	7.09e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CB—obesity	3.08e-05	7.08e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRB2—obesity	3.08e-05	7.07e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL5—obesity	3.08e-05	7.07e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CD—obesity	3.05e-05	7.01e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS1—obesity	3.03e-05	6.96e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LPL—obesity	3.01e-05	6.91e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CD—obesity	3e-05	6.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—POMC—obesity	3e-05	6.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRL—obesity	2.99e-05	6.88e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS3—obesity	2.99e-05	6.88e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FOXO1—obesity	2.99e-05	6.86e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—POMC—obesity	2.98e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RPS6KB1—obesity	2.98e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—INS—obesity	2.96e-05	6.81e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CB—obesity	2.95e-05	6.78e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STK11—obesity	2.95e-05	6.78e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL2—obesity	2.94e-05	6.75e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GNB3—obesity	2.93e-05	6.73e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—obesity	2.92e-05	6.7e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLG—obesity	2.92e-05	6.7e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—RHOA—obesity	2.91e-05	6.69e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCD—obesity	2.89e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TYK2—obesity	2.89e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT2—obesity	2.88e-05	6.63e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CB—obesity	2.88e-05	6.63e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3R1—obesity	2.88e-05	6.62e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF2—obesity	2.88e-05	6.61e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1—obesity	2.87e-05	6.59e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RHOA—obesity	2.86e-05	6.59e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT2—obesity	2.86e-05	6.59e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GNAS—obesity	2.85e-05	6.56e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FOXO3—obesity	2.85e-05	6.54e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRB2—obesity	2.84e-05	6.53e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3R1—obesity	2.84e-05	6.52e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—obesity	2.83e-05	6.5e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C3—obesity	2.82e-05	6.49e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS1—obesity	2.8e-05	6.43e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOB—obesity	2.79e-05	6.42e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CD—obesity	2.77e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCD—obesity	2.77e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS3—obesity	2.76e-05	6.35e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CD—obesity	2.75e-05	6.33e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL5—obesity	2.73e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—obesity	2.73e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—obesity	2.72e-05	6.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR2A—obesity	2.71e-05	6.23e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—obesity	2.71e-05	6.22e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GNB3—obesity	2.7e-05	6.22e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IRS2—obesity	2.69e-05	6.18e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—obesity	2.68e-05	6.17e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LPL—obesity	2.67e-05	6.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TYK2—obesity	2.67e-05	6.13e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CB—obesity	2.66e-05	6.11e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF2—obesity	2.66e-05	6.1e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FOXO1—obesity	2.65e-05	6.09e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TYK2—obesity	2.65e-05	6.09e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RHOA—obesity	2.64e-05	6.08e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RPS6KB1—obesity	2.64e-05	6.08e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GNAS—obesity	2.63e-05	6.05e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEP—obesity	2.63e-05	6.04e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—obesity	2.63e-05	6.04e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RHOA—obesity	2.63e-05	6.04e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—obesity	2.62e-05	6.02e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3R1—obesity	2.62e-05	6.02e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CAV1—obesity	2.61e-05	5.99e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3R1—obesity	2.6e-05	5.98e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOA1—obesity	2.6e-05	5.98e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOS3—obesity	2.6e-05	5.98e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOB—obesity	2.58e-05	5.93e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS2—obesity	2.58e-05	5.92e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—obesity	2.57e-05	5.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—obesity	2.52e-05	5.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—obesity	2.52e-05	5.79e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL5—obesity	2.52e-05	5.79e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—obesity	2.51e-05	5.77e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CAV1—obesity	2.5e-05	5.74e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOA1—obesity	2.49e-05	5.73e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCB—obesity	2.48e-05	5.7e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—F2—obesity	2.48e-05	5.7e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—obesity	2.48e-05	5.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LPL—obesity	2.46e-05	5.66e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCD—obesity	2.46e-05	5.65e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BAD—obesity	2.45e-05	5.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FOXO1—obesity	2.44e-05	5.62e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RPS6KB1—obesity	2.44e-05	5.61e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—obesity	2.42e-05	5.55e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—obesity	2.41e-05	5.53e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR2A—obesity	2.4e-05	5.53e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C3—obesity	2.4e-05	5.52e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—obesity	2.4e-05	5.52e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—obesity	2.4e-05	5.52e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—F2—obesity	2.38e-05	5.46e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCB—obesity	2.38e-05	5.46e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—obesity	2.37e-05	5.45e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BAD—obesity	2.35e-05	5.4e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IRS1—obesity	2.35e-05	5.39e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS2—obesity	2.28e-05	5.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—obesity	2.28e-05	5.25e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—obesity	2.28e-05	5.23e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCD—obesity	2.27e-05	5.21e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—obesity	2.26e-05	5.19e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS1—obesity	2.25e-05	5.17e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—INS—obesity	2.25e-05	5.16e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—obesity	2.24e-05	5.14e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—obesity	2.24e-05	5.14e-05	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—obesity	2.23e-05	5.12e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2A—obesity	2.22e-05	5.1e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—obesity	2.22e-05	5.09e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—obesity	2.22e-05	5.09e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOA1—obesity	2.21e-05	5.08e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—obesity	2.21e-05	5.08e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—obesity	2.19e-05	5.04e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—obesity	2.17e-05	4.99e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT2—obesity	2.17e-05	4.99e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—obesity	2.17e-05	4.98e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—INS—obesity	2.15e-05	4.95e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—obesity	2.13e-05	4.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—obesity	2.12e-05	4.87e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS2—obesity	2.11e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCB—obesity	2.11e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—obesity	2.11e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—obesity	2.11e-05	4.84e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—obesity	2.09e-05	4.8e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—obesity	2.09e-05	4.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BAD—obesity	2.08e-05	4.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—obesity	2.08e-05	4.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT2—obesity	2.08e-05	4.78e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—obesity	2.07e-05	4.75e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—obesity	2.06e-05	4.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—obesity	2.06e-05	4.74e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—obesity	2.06e-05	4.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CAV1—obesity	2.04e-05	4.7e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOA1—obesity	2.04e-05	4.69e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK8—obesity	2.03e-05	4.66e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—obesity	2.02e-05	4.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—obesity	2.02e-05	4.64e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TYK2—obesity	2.01e-05	4.61e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—obesity	2e-05	4.6e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS1—obesity	1.99e-05	4.58e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RHOA—obesity	1.99e-05	4.58e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—obesity	1.98e-05	4.55e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—obesity	1.98e-05	4.55e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3R1—obesity	1.97e-05	4.53e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—obesity	1.97e-05	4.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—obesity	1.97e-05	4.53e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCB—obesity	1.95e-05	4.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—obesity	1.95e-05	4.47e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TYK2—obesity	1.92e-05	4.42e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BAD—obesity	1.92e-05	4.42e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—obesity	1.92e-05	4.42e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—INS—obesity	1.91e-05	4.39e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RHOA—obesity	1.91e-05	4.39e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—obesity	1.89e-05	4.34e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3R1—obesity	1.89e-05	4.34e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—obesity	1.88e-05	4.32e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—obesity	1.88e-05	4.31e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—obesity	1.86e-05	4.28e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—obesity	1.85e-05	4.26e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—obesity	1.85e-05	4.25e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT2—obesity	1.85e-05	4.24e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS1—obesity	1.84e-05	4.23e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—obesity	1.82e-05	4.18e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—obesity	1.82e-05	4.18e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—obesity	1.8e-05	4.14e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—obesity	1.77e-05	4.08e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—obesity	1.77e-05	4.07e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—INS—obesity	1.76e-05	4.05e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—obesity	1.76e-05	4.04e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—obesity	1.75e-05	4.03e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—obesity	1.74e-05	4.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—obesity	1.74e-05	4.01e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—obesity	1.73e-05	3.99e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—obesity	1.72e-05	3.96e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—obesity	1.72e-05	3.95e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TYK2—obesity	1.71e-05	3.92e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—obesity	1.7e-05	3.92e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT2—obesity	1.7e-05	3.92e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RHOA—obesity	1.69e-05	3.89e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—obesity	1.69e-05	3.88e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3R1—obesity	1.67e-05	3.85e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—obesity	1.67e-05	3.85e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—obesity	1.66e-05	3.82e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—obesity	1.64e-05	3.76e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—obesity	1.62e-05	3.73e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—obesity	1.62e-05	3.72e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—obesity	1.62e-05	3.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—obesity	1.6e-05	3.67e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—obesity	1.59e-05	3.66e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—obesity	1.58e-05	3.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TYK2—obesity	1.57e-05	3.62e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RHOA—obesity	1.56e-05	3.59e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—obesity	1.55e-05	3.55e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—obesity	1.55e-05	3.55e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3R1—obesity	1.55e-05	3.55e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—obesity	1.55e-05	3.55e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK8—obesity	1.54e-05	3.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—obesity	1.53e-05	3.52e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—obesity	1.52e-05	3.48e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK8—obesity	1.47e-05	3.39e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—obesity	1.47e-05	3.38e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—obesity	1.47e-05	3.38e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—obesity	1.46e-05	3.36e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—obesity	1.44e-05	3.3e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—obesity	1.43e-05	3.28e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—obesity	1.43e-05	3.28e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—obesity	1.41e-05	3.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—obesity	1.41e-05	3.23e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—obesity	1.35e-05	3.1e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—obesity	1.34e-05	3.09e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—obesity	1.32e-05	3.04e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK8—obesity	1.31e-05	3e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—obesity	1.31e-05	3e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—obesity	1.3e-05	3e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—obesity	1.3e-05	3e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—obesity	1.3e-05	2.99e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—obesity	1.3e-05	2.98e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—obesity	1.25e-05	2.88e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—obesity	1.25e-05	2.87e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—obesity	1.24e-05	2.85e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK8—obesity	1.21e-05	2.77e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—obesity	1.2e-05	2.77e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—obesity	1.19e-05	2.75e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—obesity	1.19e-05	2.75e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—obesity	1.11e-05	2.55e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—obesity	1.11e-05	2.55e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—obesity	1.11e-05	2.55e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—obesity	1.1e-05	2.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—obesity	1.06e-05	2.44e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—obesity	1.02e-05	2.36e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—obesity	1.02e-05	2.35e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—obesity	9.82e-06	2.26e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—obesity	9.42e-06	2.17e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—obesity	9.41e-06	2.16e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—obesity	9.06e-06	2.08e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—obesity	8.7e-06	2e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—obesity	8.68e-06	2e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—obesity	8.35e-06	1.92e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—obesity	7.7e-06	1.77e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—obesity	7.7e-06	1.77e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—obesity	7.11e-06	1.63e-05	CbGpPWpGaD
